Status:
COMPLETED
A Crossover Study in the Treatment of Patients With COPD
Lead Sponsor:
Dey
Conditions:
Chronic Obstructive Pulmonary Disease
Eligibility:
All Genders
40+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to compare the efficacy of Formoterol Fumarate Inhalation Solution (FFIS) 20 mcg BID to Combivent® Inhalation Aerosol \[2 inhalations from metered dose inhaler (MDI)of 18 ...
Eligibility Criteria
Inclusion
- Diagnosis of COPD
- Smoker or exsmoker with at least 10 years smoking at least one pack of cigarettes per day
- Meet lung function requirements
Exclusion
- Diagnosis of Asthma
- Significant disease other than COPD
- Female pregnant or lactating or planning to become pregnant
Key Trial Info
Start Date :
May 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2007
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00462540
Start Date
May 1 2007
End Date
October 1 2007
Last Update
March 4 2009
Active Locations (15)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
San Diego, California, United States, 92120
2
Research Site
Denver, Colorado, United States, 80206
3
Research Site
Wheat Ridge, Colorado, United States, 80033
4
Research Site
Panama City, Florida, United States, 32405